专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2011128630A2 ANTI-ABUSE GELLED PHARMACEUTICAL COMPOSITIONS 审中-公开
标题翻译：抗生素胶质药物组合物
公开(公告)号：WO2011128630A2
公开(公告)日：2011-10-20
申请号：PCT/GB2011/000560
申请日：2011-04-11
申请人： PROBIO ASA , DRAGET, Kurt, Ingar , HAUG, Ingvild, Johanne , ENGELSEN, Steinar, Johan , SETERNES, Tore , COCKBAIN, Julian , HATTREM, Magnus, M
发明人： DRAGET, Kurt, Ingar , HAUG, Ingvild, Johanne , ENGELSEN, Steinar, Johan , SETERNES, Tore , HATTREM, Magnus, M
IPC分类号： A61K9/06 , A61K9/107 , A61K47/36 , A61K47/42 , A61K47/44
CPC分类号： A61K9/107 , A61K9/0056 , A61K9/06 , A61K47/36 , A61K47/42 , A61K47/44
摘要： This invention provides an oral pharmaceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion containing a drug of abuse.
摘要翻译：本发明提供一种口服药物组合物，其包含含有滥用药物的生理上可耐受的胶凝水包油乳液。

2. 发明申请

WO2011124895A2 PHOSPHOLIPID-CONTAINING PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS 审中-公开
标题翻译：含磷脂的药物和营养组合物
公开(公告)号：WO2011124895A2
公开(公告)日：2011-10-13
申请号：PCT/GB2011/000548
申请日：2011-04-08
申请人： PROBIO ASA , DRAGET, Kurt, Ingar , HAUG, Ingvild , CARLSEN, Anne-Ma, H. , SETERNES, Tore , COCKBAIN, Julian
发明人： DRAGET, Kurt, Ingar , HAUG, Ingvild , CARLSEN, Anne-Ma, H. , SETERNES, Tore
IPC分类号： A61K31/683
CPC分类号： A61K31/685 , A23K20/10 , A23K20/158 , A61K31/683 , A61K47/24
摘要： This invention provides a pharmaceutical composition comprising a physiologically tolerable phospholipid selected from the group consisting of marine phospholipids and lecithin and said physiologically tolerable phospholipid having dispersed therein a physiologically tolerable, lipophilic, structure disrupting agent phospholipid having lipophilic, structure disrupting agent.
摘要翻译：本发明提供一种药物组合物，其包含选自海洋磷脂和卵磷脂的生理学上可耐受的磷脂和所述生理上可耐受的磷脂，其中分散有具有亲脂性，结构破坏剂的生理上可耐受的亲脂性结构破坏剂磷脂。

3. 发明申请

WO2010112870A1 METHOD OF ANALYSIS OF CARDIAC IMAGES 审中-公开
标题翻译：心脏图像分析方法
公开(公告)号：WO2010112870A1
公开(公告)日：2010-10-07
申请号：PCT/GB2010/000661
申请日：2010-04-01
申请人： UNIVERSITETET I STAVANGER , EFTESTØL, Trygve , WOIE, Leik , COCKBAIN, Julian
发明人： EFTESTØL, Trygve , WOIE, Leik
IPC分类号： G06T7/00
CPC分类号： G06T7/0012 , G06T7/41 , G06T2207/10072 , G06T2207/10116 , G06T2207/10132 , G06T2207/20108 , G06T2207/30048
摘要： The invention relates to a method of image analysis of a cardiac image of a human subject who has experienced a myocardial infarction, said method comprising: delineating an area of said image corresponding to scar tissue within myocardium; from the voxel data for said area, determining at least one value indicative of the likelihood of future cardiac arryhthmia; and optionally applying to said value a prediction matrix generated from the same value for other human subjects who have had a myocardial infarction and who have subsequently experienced cardiac arryhthmia.
摘要翻译：本发明涉及一种经历心肌梗塞的人类受试者的心脏图像的图像分析方法，所述方法包括：描绘对应于心肌内的瘢痕组织的所述图像的区域; 从所述区域的体素数据中，确定指示未来心脏心律失常的可能性的至少一个值; 并且可选地向所述值应用由具有心肌梗塞并随后经历心脏心律失常的其他人类对象的相同值产生的预测矩阵。

4. 发明申请

WO2008125828A3 OLIGO-GULURONATE AND GALACTURONATE COMPOSITIONS 审中-公开
公开(公告)号：WO2008125828A3
公开(公告)日：2008-10-23
申请号：PCT/GB2008/001287
申请日：2008-04-11
申请人： NTNU TECHNOLOGY TRANSFER AS , COCKBAIN, Julian , TAYLOR, Catherine , DRAGET, Kurt, Ingar , SMIDSRØD, Olav, Åsmund
发明人： TAYLOR, Catherine , DRAGET, Kurt, Ingar , SMIDSRØD, Olav, Åsmund
IPC分类号： A61K31/715 , A61K45/06 , A61P11/00
摘要： The invention provides a pharmaceutical composition comprising a macromolecular drug and an oligoguluronate or oligogalacturonate, e.g. having a number average degree of polymerization in the range 5 to 18, a guluronate (or galacturonate) fraction (FG)of at least 0.80, a mannuronate fraction (FM) of no more than 0.20, and having at least 95% mole with a degree of polymerization less than 20. The composition may be used in a method of treatment which comprises administering the composition to a mucosal surface in a human or non- human vertebrate subject.

5. 发明申请

WO2007060473A1 METHOD OF CULTURING UNICELLULAR ORGANISMS 审中-公开
标题翻译：培养细菌有机体的方法
公开(公告)号：WO2007060473A1
公开(公告)日：2007-05-31
申请号：PCT/GB2006/004443
申请日：2006-11-28
申请人： STATOIL ASA , COCKBAIN, Julian , KOTLAR, Hans, Kristian , BRAKSTAD, Odd, Gunnar , WINNBERG, Asgeir , MARKUSSEN, Sidsel
发明人： KOTLAR, Hans, Kristian , BRAKSTAD, Odd, Gunnar , WINNBERG, Asgeir , MARKUSSEN, Sidsel
IPC分类号： C12M1/34 , C09K8/58
CPC分类号： C12M35/04 , C09K8/582
摘要： The invention provides a method of producing a culture of subterranean microorganisms, said method comprising: obtaining a sample of pressurized fluid from a subterranean reservoir; while maintaining said sample under pressure transferring it into a fermentation reactor; and incubating said sample in said reactor under elevated pressure.
摘要翻译：本发明提供了一种生产地下微生物培养的方法，所述方法包括：从地下储层获得加压流体样品; 同时保持所述样品在压力下将其转移到发酵反应器中; 并在升高的压力下将所述样品在所述反应器中孵育。

6. 发明申请

WO2007039754A1 USE OF OLIGOURONATES FOR TREATING MUCUS HYPERVISCOSITY 审中-公开
标题翻译：使用奥利膦酸治疗肌肉高血压
公开(公告)号：WO2007039754A1
公开(公告)日：2007-04-12
申请号：PCT/GB2006/003720
申请日：2006-10-06
申请人： NTNU TECHNOLOGY TRANSFER AS , COCKBAIN, Julian , TAYLOR, Catherine , DRAGET, Kurt, Ingar , SMIDSROD, Olav, Asmund
发明人： TAYLOR, Catherine , DRAGET, Kurt, Ingar , SMIDSROD, Olav, Asmund
IPC分类号： A61K45/06 , A61K31/715 , A61P11/00 , A61K9/12
CPC分类号： A61K9/0073 , A61K9/007 , A61K31/715 , A61K45/06 , A61K2300/00
摘要： The invention provides a method of treatment of a human or non-human subject to combat mucosal hyperviscosity in the respiratory tract, which method comprises application to a mucosal surface in said tract in said subject of an effective amount of a physiologically tolerable oligouronate.
摘要翻译：本发明提供一种治疗人或非人受试者抵抗呼吸道粘膜高粘度的方法，该方法包括在有效量的生理上可耐受的寡聚糖酸盐的情况下将所述受试者的所述道中的粘膜表面施用。

7. 发明申请

WO2007003954A1 CARBON DIOXIDE EXTRACTION PROCESS 审中-公开
标题翻译：二氧化碳提取工艺
公开(公告)号：WO2007003954A1
公开(公告)日：2007-01-11
申请号：PCT/GB2006/002511
申请日：2006-07-06
申请人： STATOIL ASA , COCKBAIN, Julian , SIVERTSEN, Børge, Rygh , RUESLÅTTEN, Håkon , KROGH, Bente
发明人： SIVERTSEN, Børge, Rygh , RUESLÅTTEN, Håkon , KROGH, Bente
IPC分类号： B01D53/14 , C04B35/057 , C01B3/56 , B01J8/02 , B01J8/04 , B01J8/06
CPC分类号： C01B3/384 , B01D53/1475 , B01D53/62 , B01D2251/404 , B01D2251/602 , C01B3/48 , C01B3/56 , C01B3/583 , C01B3/586 , C01B2203/0233 , C01B2203/0283 , C01B2203/0288 , C01B2203/042 , C01B2203/043 , C01B2203/044 , C01B2203/0445 , C01B2203/047 , C01B2203/0475 , C01B2203/066 , C01B2203/1241 , C04B33/04 , C04B35/057 , C04B2235/3208 , C04B2235/349 , Y02C10/04 , Y02C10/06 , Y02P20/152
摘要： The invention relates to a process for the extraction of carbon dioxide from a carbon dioxide-containing gas by calcium oxide by formation of calcium carbonate, said process comprising flowing said carbon dioxide- containing gas past or through a gas-porous, calcium oxide-containing ceramic member disposed in a reactor vessel whereby said carbon dioxide-containing gas may permeate said member, and preferably subsequently heating said member and/or exposing said member to a gas having a lower carbon dioxide partial pressure than said carbon dioxide-containing gas whereby to cause calcium carbonate therein to release carbon dioxide, said member defining at least part of the inner wall of a gas flow conduit within said reactor vessel.
摘要翻译：本发明涉及通过形成碳酸钙从含二氧化碳的气体中通过氧化钙从二氧化碳气体中提取二氧化碳的方法，所述方法包括使含二氧化碳的气体通过或通过气体，含氧化钙的气体陶瓷构件设置在反应器容器中，其中所述含二氧化碳的气体可以渗透所述构件，并且优选地随后加热所述构件和/或将所述构件暴露于具有比所述含二氧化碳的气体低的二氧化碳分压的气体，由此至导致其中的碳酸钙释放二氧化碳，所述构件限定所述反应器容器内的气体流动导管的内壁的至少一部分。

8. 发明申请

WO2006120425A1 PROCESS FOR THE PRODUCTION OF A LOW MOLECULAR WEIGHT HEPARIN 审中-公开
标题翻译：生产低分子量肝素的方法
公开(公告)号：WO2006120425A1
公开(公告)日：2006-11-16
申请号：PCT/GB2006/001690
申请日：2006-05-09
申请人： UNIVERSITETET FOR MILJØ-OG BIOVITENSKAP , COCKBAIN, Julian , FLENGSRUD, Ragnar , ØDEGAARD, Ole, Rasmus
发明人： FLENGSRUD, Ragnar , ØDEGAARD, Ole, Rasmus
IPC分类号： C08B37/10
CPC分类号： C08B37/0078 , A23L33/10 , A23L33/28
摘要： The invention provides a process for the production of a very low molecular weight heparin (VLMWH) composition having a VLMWH content, relative to total heparin content, of at least 10% wt, said process comprising chromatographically or chemically or by filtration reducing the relative proportion of heparin having a molecular weight above 8000Da in a heparin composition extracted from a non-mammalian, vascularised marine animal.
摘要翻译：本发明提供了一种生产相对于总肝素含量为至少10重量％的VLMWH含量的非常低分子量肝素（VLMWH）组合物的方法，所述方法包括色谱或化学或通过过滤降低相对比例在从非哺乳动物血管海洋动物中提取的肝素组合物中具有高于8000Da分子量的肝素。

9. 发明申请

WO2006090185A1 METHOD OF PROGNOSIS OF MENTAL DISEASES, E. G. AUTISM AND CEREBRAL PALSY 审中-公开
标题翻译：精神病预防方法，E. G. AUTISM和CEREBRAL PALSY
公开(公告)号：WO2006090185A1
公开(公告)日：2006-08-31
申请号：PCT/GB2006/000699
申请日：2006-02-28
申请人： TIPOGEN AS , COCKBAIN, Julian , HOOVER, Frank
发明人： HOOVER, Frank
IPC分类号： G01N33/68
CPC分类号： C12Q1/6888
摘要： The invention provides a method of prognosis for applied behavioural analysis treatment of mental disease, in particular autism or cerebral palsy, in a human subject, said method comprising analyzing a sample of body tissue or fluid from said subject for the presence or absence of a chemical marker indicative of the likelihood of success or failure of applied behavioural analysis treatment of said mental disease, and optionally, based on said analysis, beginning, continuing or ceasing applied behavioural analysis treatment of said subject. The sample is preferably an urine sample, and the preferred prognostic markers are: gluten derivatives, indolyl-3-acryloylglycine (IAG) , serotonin uptake stimulator, β-casomorphineamides, gliadinomorphine, β-casomorphines, deltorphins, Demorphine, glutemorphine , gluten exophins, compounds of molecular weight of 687 Daltons.
摘要翻译：本发明提供了一种对人类受试者的精神疾病，特别是自闭症或脑性麻痹的应用行为分析治疗的预后的方法，所述方法包括分析来自所述受试者的身体组织样品或液体存在或不存在化学物质指示所述精神疾病的应用行为分析治疗的成功或失败的可能性的标记，以及任选地基于所述分析，开始，继续或停止所述受试者的应用行为分析治疗。样品优选为尿液样品，优选的预后标记是：谷蛋白衍生物，吲哚基-3-丙烯酰甘氨酸（IAG），5-羟色胺摄取刺激剂，β-吗啡酰胺，麦醇溶蛋白吗啡，β-casomorphine，deltorphins，吗啡，谷氨吗啡，麸质外蛋白，分子量为687道尔顿的化合物。

10. 发明申请

WO2006048671A1 POLYAMINE COMPOSITIONS 审中-公开
标题翻译：聚氨酯组合物
公开(公告)号：WO2006048671A1
公开(公告)日：2006-05-11
申请号：PCT/GB2005/004279
申请日：2005-11-07
申请人： BIOFORSKNING AS , COCKBAIN, Julian , LØVAAS, Erik
发明人： LØVAAS, Erik
IPC分类号： A61Q19/08 , A61K8/41
CPC分类号： A61Q19/08 , A61K8/41
摘要： The invention provides the use of an unbranched aliphatic polyamine for the manufacture of a topical skin treatment composition for use in the topical treatment of skin to achieve at least one of the effects of combating age-related skin pigmentation, promoting skin elasticity, enhancing skin colour and enhancing skin smoothness.
摘要翻译：本发明提供了无支链脂族多胺用于制造用于局部治疗皮肤的局部皮肤治疗组合物的用途，以实现与年龄相关的皮肤色素沉着，促进皮肤弹性，增强肤色的抗击作用中的至少一种并增强皮肤光滑度。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式